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1. Introduction
  Despite vigorous researches and prophylactic measures on 
HIV/AID, the infection and the disease conditions continue 
to threaten the life of millions of people in Africa. The 
continued surge of HIV/AIDS in Africa can be attributed to 
the influence of so many other factors on pathogenesis of the 
disease condition. Considering the fact that many infectious 
agents are endemic in sub-Saharan Africa, many immune 
complexes are formed and the presence of circulating 
immune complexes (CICs) in normal individuals stimulate 
Objective: To investigate the prevalence of microbial antigenic components of circulating 
immune complexes amongst grades of CD4 T lymphocyte counts in HIV sero positive and sero-
negative participants. Methods: Polyethelene glycol (PEG-600) and buffering methods of 
precipitation and dissociation of immune complexes was used to generate immune solution from 
sera of 100 HIV sero-positive and 100 HIV sero-negative participants. These were categorized 
into 3 grades based on CD4 count: > 500 cell/mm3, 200-499 cell/mm3 and <200 cell/mm3. The 
immune solutions were assayed using membrane based immunoassay and antibody titration, 
along side its unprocessed serum for detection of various microbial antigens and or antibodies. 
CD4 T cell counts were estimated using Patec Cyflow SL-3 Germany. Results: Antigenic 
component of immune complexes of various infectious agents was detected in 99 and 70 HIV sero-
positive and HIV sero-negative participants, respectively. In group A, there were 10 HIV positive 
participants, including 4 (40.0%) had circulating immune complexes(CICs) due to Salmonella 
species only; 1(10.0%) due to Salmonella-Plasmodium falciparum (P. falciparum), Salmonella- 
P. falciparum-HCV and P. falciparum antigens, respectively. In group B, 45(45.4%) HIV sero-
positive participants with CICs had CD4 T lymphocyte count between 200-499 cells/mm3. Out 
of these, 20(44.4%) had CICs due to Salmonella species only; 9(20%) due to Salmonella-P. 
falciparum. In group C, there were 44(44.4%) HIV sero-positive participants, including 3(6.8%) 
due to Salmonella species only; 24(54.4%) due to Salmonella-P. falciparum; 2(4.5%) due to P. 
falciparum only. Conclusions: In HIV sero-positive participants, presence of heterogeneity of 
Salmonella species-P. falciparum antigens was highly incriminated in CD4 count depletion but 
not homogeneity of malaria parasites antigens. Malaria parasites antigens only were incriminated 
in CD4+ count depletion amongst HIV sero-negative participants. Before taking any decision on 
the management of HIV-1-positive individuals, their malaria and Salmonella paratyphi status 
should be assessed, but not malaria status alone.
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many immuno pathological conditions ranging from chronic 
inflammatory responses to organ tissue damage[1]. Based on 
this, one may begin to fathom the faith of HIV sero-positive 
participants who are already exposed to debilitating disease 
and immunocompromised. It suggested that soluble immune 
complex diseases arising after infections may result from 
the liberation of partially synthesized bacterial polypeptide 
or viral nucleic acid antigens. These disrupted antigens 
will have heterogeneous molecular weights due to antigenic 
material which is incomplete as a result of premature 
termination of synthesis. Antigens of this type result in 
significant soluble complex formation in vitro when reacted 
with antisera from many individuals[2,3]. 
  Before now no critical studies have been done on the 
clinical roles of immune complexes formed by infectious 
agents in HIV sero-positive patients especially in Africa 
where many microbial agents can be found. Moreover it 
remains an aberration that the most incriminated infectious 
agents in immune complex formation constitute greater 
burden amongst HIV sero-positive participants in Nigeria 
and sub-Saharan Africa. Earlier work has shown that CICs 
are highly retained in HIV/AIDS sero-positive subjects 
compared to HIV sero-negative subjects[4,5].
  In the present study, we are able to look into the condition 
of CD4 T lymphocyte count in the presence of this antigen-
antibody as CICs, and the number of HIV sero-positive 
participants retaining these immune complexes. We decided 
to characterize the microbial antigenic components of CICs 
to ascertain the prevailing microbial agents or opportunistic 
infections in formation of CICs which may contribute great 
deal a burden to the immune-compromised HIV/AIDS 
hosts, and to find out the immunological influence of these 
antigens on CD4 T lymphocyte counts in these participants. 
In the present study, the characterized antigens were viewed 
as collection of possible existing clinical or subclinical HIV 
associated immuno-suppressive agents especially by Th-2 
type immune response. 
2. Materials and methods
  A total of 200 (100 HIV sero positive participants and 100 
HIV sero negative control) were randomly selected from 
subjects who attended clinics at Nnamdi Azikiwe University 
Teaching Hospital, (HIV Unit) Nnewi Campus. The mean 
age of the participants was 35 years. The participants 
were grouped into 3 based on Center for Diseases Control 
(CDC) classification of HIV/AIDS with emphasis on CD4+ T 
lymphocyte counts. Group A: (CD4 count>500 cells/mm3); 
Group B: (CD4 count 201-499 cells/mm3) and Group C (CD4 
count<200 cells/mm3)[6]. The participants were given by 
informed consent. The ethical committee of the Nnamdi 
Azikiwe University Teaching  Hospital Nnewi gave approval 
for the work. Ten mL of blood was collected from each 
participant, 8 mL was dispensed in vaccutainer tube for 
serum extraction, while 2 mL was dispensed in EDTA -K2 
anticoagulant container for CD4+ count (The blood samples 
for CD4 count were assayed within 6 hours of collection each 
day). The sera extracted were treated with Polyethelene 
glycol of molecular weight 6000 (PEG 6000) to produce what 
we termed immune solution. The immune solutions were 
stored at 4 曟 and were assayed the following day. 
2.1. CICs precipitation
  The polyethylene glycol (PEG) precipitation technique as 
described by Adriana et al[7], with minor modifications was 
used. Briefly, 1 mL of 8% (average molecular weight, 6000) 
PEG6000, Sigma, St. Louis in 0.1 M borate buffer (pH 8.4) 
was added drop wise with constant stirring to 1 mL of serum 
collected from the participant. The tubes were vortexed and 
incubated at 4 曟, for 3 hours, and centrifuged at 8 320 g 
for 15 minutes. Supernatants were carefully removed. The 
resultant pellet was re-suspended and washed twice with 
2 mL of 4% PEG solution in the same buffer, removing the 
supernatant carefully each time. After the second spin, the 
solutions were treated with 1 mL 0.01M phosphate buffer 
saline (PBS) (pH 7.2), and kept as immune solutions in the 
PBS buffer at 4 曟 and assayed serologically the following 
day for Salmonella typhi antibodies O and H, Salmonella 
paratyphi A, B, C antibodies, Plasmodium falciparum (P. 
falciparum) antigens, Hepatitis B surface antigen (HbsAg), 
Hepatitis C virus (HCV), Mycobacterium tuberculosis 
antigens, Helicobacter pylori (H. pylori) antigens and 
Treponema pallidum antigens. 
2.2. Detection of microbial antigens
  The colourless clear immune solution containing 
dissociated antigens and antibodies of various microbial 
origins was assayed using specific membrane based 
immunoassay for separate detection of P. falciparum 
antigens, HbsAg antibodies, HCV antibodies, Mycobacterium 
tuberculosis antibodies, H. pylori antibodies and Treponema 
pallidum antibodies. The method was as described by the 
manufacturer of the immunoassay kits (Acon Incorporated 
USA).   
2.3. Detection of Salmonella antigens
  Detection of Salmonella antigens in the immune solution 
was done using monoclonal antibody (MAbs) (anti-somatic 
and anti-flagellins IgG) (Antec Diagnostics, United 
Kingdom), raised against Salmonella typhi and Salmonella 
paratyphi antigens. This reacted against the representatives 
of known Salmonella typhi and Salmonella paratyphi 
antigens (Antec diagnostics United Kingdom) as control; 
Salmonella typhi and Salmonella paratyphi antigens in 
the immune solution and against the un processed serum 
in 2 fold dilutions of solution respectively (1:10, 1:20, 1:40, 
1:80, 1:160), using tube agglutination method. Presence of 
agglutination in each tube is an indication of presence of 
Salmonella typhi or Salmonella paratyphi antibodies in the 
immune solution and unprocessed sera, respectively. The 
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highest dilution with agglutination, was taken as the titre 
of antibody in the immune solutions or unprocessed sera, 
respectively.
2.4. Statistical analysis
  One-Way ANOVA was applied using Post Hoc Multiple 
Comparisons (Game-Howell), with significance level of 0.05 
at 95% confidence interval. 
3. Result
  The band colour on the strip was deeper using immune 
solution than that of the results obtained using unprocessed 
serum. Higher antibody titre was obtained from the immune 
solution than the unprocessed serum.  
  A total of 99 (99.0%) HIV sero-positive participants and 70 
(70.0%) HIV sero-negative participants had various microbial 
antigens-antibodies as CICs. The CD4 of HIV sero-positive 
participants was significantly reduced compared to CD4 of 
HIV sero-negative participants [ (248依159) cells/mm3 vs (541
依215) cells/mm3] (P<0.001). And CD4+ count of HIV sero-
negative participants without CICs was significantly higher 
than that of HIV sero-negative participants with CICs [(646依
219) cells/mm3 vs (248依159) cells/mm3] (P<0.05). 
  In Group A, 10 HIV positive participants with CICs had CD4 
T lymphocyte count above 500 cells/mm3, including 4(40.0%) 
had CICs due to Salmonella species only; 3(30.0%) due to 
Salmonella-HCV; 1(10.0%) due to Salmonella-P. falciparum, 
Salmonella- P. falciparum-HCV and P. falciparum 
antigens, respectively. On the other hand, out of the 70 HIV 
sero-negative participants with CICs, 39(55.7%) had CD4+ 
T cell count above 500 cell/mm3, including 15(39.5%) had 
CICs due to Salmonella species only; 13(34.2%) due to P. 
falciparum only; 8(21.1%) due to Salmonella-P. falciparum; 
2(5.2%) due to HCV only and 1(2.5%) due to Salmonella-P.
falciparum-HCV antigens combined. Similarly, out of 30 HIV 
sero-negative participants without CICs, 18(60.0%) had CD4+ 
T cell count above 500 cell/mm3. The mean CD4+ T cell count 
of HIV sero-negative participants was higher than that of 
HIV sero-positive participants [(692依154) cells/mm3 vs (649依
133) cells/mm3] (P>0.05). 
  In Group B, 45(45.4%) HIV sero-positive participants 
with CICs had CD4 T lymphocyte count between (200依
499) cells/mm3. Out of these, 20(44.4%) had CICs due to 
Salmonella species only; 9(20.0%) due to Salmonella-P. 
falciparum; 7(15.5%) due to Salmonella-HCV; 2(4.4%) 
due to Salmonella-P. falciparum-HBV; 1(2.2%) due to 
P. falciparum-HCV, P. falciparum- H. pylori, H. pylori 
only, Salmonella-P. falciparum-HCV, Salmonella-HBV- 
H. pylori, Salmonella-P. falciparum-HCV-HBV, and 
Salmonella-HBV-HCV, respectively. The only HIV sero-
positive subject without CICs, fall in this category, making a 
total of 46 HIV sero-positive subjects in this group. On the 
other hand, out of the 70 HIV sero-negative participants with 
CICs, 28(40.0%) had CD4 T cell count above 200 cell/mm3, 
including 3(10.7%) due to Salmonella species only; 12(42.0%) 
due to P. falciparum only; 12(42.0%) due to Salmonella-P. 
falciparum; 1(3.5%) due to HCV only, Salmonella-P. 
falciparum-HCV and Salmonella-HCV, respectively. Out of 
the 30 HIV sero-negative subjects free from CICs, 12(40.0%) 
had CD4 T cell count above 200 cell/mm3. The mean CD4+ T 
cell count of HIV sero-negative subjects was significantly 
higher than that of HIV sero-positive subjects [(370依79) 
cells/mm3 vs (304依73) cells/mm3] (P<0.05). Besides, the mean 
CD4 count of the HIV sero-negative participants free from 
CICs was significantly higher than that of HIV sero-negative 
participants with CICs [(452依27) cells/mm3 vs (370依79) cells/
mm3] (P<0.01) and that of HIV sero-positive participants with 
CICs [(452依27) cells/mm3 vs (304依73) cells/mm3] (P<0.01). 
  In Group C, 44(44.4%) HIV sero-positive participants 
with CICs had CD4 T lymphocyte count below 200 cells/
mm3, including 3(6.8%) due to Salmonella species only; 
24(54.4%) due to Salmonella-P. falciparum; 7(15.9%) 
due to Salmonella-P. falciparum-HCV; 2(4.5%) due 
to Salmonella-P. falciparum-HBV; 2(4.5%) due to 
Salmonella-P. falciparum-H. pylori; 2(4.5%) due to 
P. falciparum only; 1(2.2%) due to Salmonella-HBV, 
P. falciparum-HCV, P. falciparum-H. pylori  and 
Salmonella-P. falciparum-HCV-HBV, respectively. On the 
other hand, out of the 70 HIV sero-negative participants with 
CICs, 3(4.3%) had CD4 count below 200 cells/mm3, and no 
had CICs due to Salmonella species only. One (33.3%) had 
CICs due to P. falciparum only, Salmonella-P. falciparum 
and Salmonella-P. falciparum-HCV, respectively. The 
mean CD4+ T cell count of HIV sero-negative participants 
with CICs in this group was significantly higher than that of 
HIV positive with CICs [(172依12) cells/mm3 vs (124依48) cells/
mm3],  and non was found in HIV negative without CICs. 
4. Discussion
  HIV/AIDS subjects were subjected to immune complex 
studies, with special interest on identifying the antigenic 
components of the immune complexes. The occurrence 
of CICs is an event in any normal immune response. The 
half-life of such CIC is transitory in nature. Continued 
presence of CIC over extended periods, however, is a cause 
of consequence of some pathological condition or infection. 
Elevated levels of CIC have been found in a variety of diseases 
including infectious diseases, neoplasia, collagen vascular 
diseases[2,3]. In this study we analyzed the status of CD4 count 
in the presence of CICs considering the immune-clinical 
importance of CD4 count.
  Data obtained from this work showed that the mean CD4 T 
cell count of HIV sero-positive participants is significantly 
lower than that of HIV sero-negative participants with CICs. 
The result has shown that more number of HIV sero-positive 
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participants would retain antigen-antibodies as CICs. 
The estimation of CD4 T lymphocyte count in HIV sero-
negative participants as well, has helped us to compare 
the level of CD4 T lymphocyte count in both statuses in the 
presence of CICs. Amongst these participants in Group A, 
very low percentage (10%) of HIV sero-positive participants 
would have CD4 T lymphocyte count above 500 cell/mm3 in 
the presence of CICs. While about 39(55.7%) of HIV sero-
negative participants would have CD4 count above 500 cell/
mm3 in the presence of CICs. This indicates that retention 
of CICs soluble or insoluble, is a great burden to HIV/AIDs 
participants. For 70% of HIV sero-negative participants 
with CICs, it indicated that many patients in Africa habour 
CICs due to high prevalence of numerous microbial agents. 
This findings support the work of Tanyigna et al[9], that 
serum levels of CIC in Nigerians are  elevated. one would 
expect that since the 70 participants do not HIV, up to 
99% of them should have CD4 count above 500 cell/mm3. 
However, only 55.7% have CD4 count above 500 cell/mm3. 
There may be other factors other than HIV viral infections, 
adversely affecting CD4 count. The level of depletion 
of CD4 count may be determined by the type of antigen 
and the rate of formation of immune complex. This is in 
line with the report from Center for Disease Control and 
Prevention (CDC) stating that there are cases of Idiopathic 
low CD4+ T Lymphocyte count. CDC defined this condition 
as Idiopathic CD4 lymphocytopenia with <300 CD4 cells 
per mm3 or a CD4 cell count of < 20% of the total T cells on 
two occasion, no evidence of HIV type 1 or 2 infection and 
the absence of any defined immunodeficiency or therapy 
associated with depressed levels of CD4 cell count[6]. This 
study revealed that heterogeneous  circulation of Salmonella 
species and P. falciparum antigens, is highly incriminated 
in CD4 count depletion in both HIV sero-positive and sero-
negative participants. We also hypothesize here that malaria 
parasite as a single co-infection with HIV infection is not 
incriminated in CD4 count depletion. Instead, such pattern 
of infection was found to cause CD4 count depletion in HIV 
sero-negative than in HIV sero-positive participants. In 
support of this finding Chirenda[10] reported that more HIV-
negative malaria cases had severely lowered CD4 counts 
than HIV-positive cases did. He reported that in 8 of 19 
(42%) HIV-negative cases with malaria parasite had CD4 
count below 200, while only 31 of 78(40%) HIV-positive cases 
had CD4 counts below 200. It is hypothesized that malaria 
reduces the CD4 count more than HIV infection[10]. In a 
similar development, Geertruyden et al reported that after 
successful antimalarial treatment, the median CD4 count 
at day 28 of follow-up increased from 468 to 811 cells/毺L in 
HIV-1-negative and from 297 to 447 cells/毺L in HIV-1-
positive patients, and that after successful treatment, the 
proportion of patients with CD4 count <200/毺L at day 45 
decreased from 9.6% to 0% in HIV-1-negative and from 
28.7% to 13.2% in HIV-1-positive malaria patients[11]. 
However, both Chirenda and Geertruyden et al focused only 
on malaria parasites, but our work involved heterogeneity 
and homogeneity pattern of infection. 
  Our data also showed that 30 HIV sero-negative 
participants that do not have CICs have  mean CD4 count 
significantly above that of 70 others with CICs (P<0.05). 
Hence CD4 count depletion is not bizarre to HIV infection[12]. 
Since 99% of the HIV sero-positive participants retain 
antigens as components of immune complexes, virtually all 
HIV sero-positive participants would continue to suffer the 
consequences of immuno pathological effect due to presence 
of these antigens-antibodies bound together as immune 
complexes. 
  Out of the 100 HIV sero-positive participants, 19(19.0%) 
were on retroviral therapy. These 19 participants retained 
antigen-antibodies as CICs. This is an indication that 
retroviral drug reduces the viral load but does not eliminate 
immune complexes or prevent the formation. So the 
problems in suppressing HIV infection in Africa is not only 
on therapy but also epidemiological and secondary factors as 
mentioned above. With the avalanche of microbial antigens-
antibodies detected in this work contributing to CICs 
formation and retention, this work has confidently shown 
that this HIV infected patients are readily exposed to many 
co-infectious agents ranging from bacteria, parasites and 
viruses. immuno-pathological effect would be continuous 
due to wide spread of infectious agents and their continuous 
infection and re-infection of HIV patients. 
  In group B, 45(45.4%) of 99 HIV sero-positive participants 
with CICs had CD4+ counts above 200 cell/mm3 while 
28(40.0%) of 70 HIV sero-negative participants with CICs 
had CD4 count above 200 cell/mm3. With reduced CD4 
count, the number of HIV sero-negative participants with 
immune complexes dropped from 39 to 28 while number 
of HIV sero-positive participants significantly rising from 
10 to 45 (P<0.01), with increase in number of Salmonella-
malaria parasites co-infection. The presence of Salmonella 
antigen alone may not be a threat to CD4 count in HIV sero-
negative participant but P. falciparum only or combination 
of Salmonella-P. falciparum antigens. 
  Our report has revealed higher incidence of HCV than HBV 
co-infection with HIV using analysis of immune complexes. 
Same transmission pattern of HIV, HCV and HBV co-
infection is not an uncommon feature. Our report suggests 
that HCV is commonly associated in immune complexes in 
the sera of HIV-infected patients and that they may retain 
HCV more than HBV in patients co-infected with the HIV-
HCV-HBV, or just HIV-HCV co-infection. On the other hand, 
this simply indicates that there is higher prevalence of HCV 
than HBV in HIV sero-positive participants in this locality. 
  CDC have rated the HIV sero-positive participants in group 
C as those with AIDS whose condition is critical and may 
remain in this condition without recovering[6]. Only 3 HIV 
sero-negative participants with components of immune 
complexes had heterogeneity of Salmonella-P. falciparum, 
homogeneity of malaria parasites infection and heterogeneity 
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of Salmonella-P. falciparum-HCV, respectively. On 
the other hand, 44 HIV sero-positive participants were 
found out of which 24 have heterogeneous infection of 
Salmonella-P. falciparum, but non had single infection of 
malaria parasite. The reason is not ascertained but certain 
immuno-pathological involvements must be the cause 
of immunological depression other than HIV. In support 
of this report, Marita and Klavs earlier suggested that if 
we are to intervene successfully to eradicate infections 
or prevent immune pathology either by vaccination or 
other immune intervention therapies it will be crucial to 
understand how co-infections with different pathogens 
affect the adaptive immunity and the establishment of 
immunological memory[13]. None of the 30 HIV sero-negative 
participants without CICs had CD4 count 201-499 cells/
mm3 or <200 cells/mm3. This supports the findings in this 
study that the presence of immune complexes resulting 
from these infectious agents is a considerable factor in HIV 
pathogenesis and in CD4 count depletion both in HIV sero-
positive and sero negative participants.
  Consistent formation of immune complexes due to 
consistent microbial infection and re-infection of HIV sero-
positive participants should be regarded as serious source 
of worries in Nigeria, African countries and other parts of 
the world where microbial agents are endemic. Almost all 
HIV sero-positive patients in Africa would retain antigens 
and antibodies as immune complexes. Persistence of 
these antigens in the body is a contributory factor to HIV 
progression and other epidemiological problems being 
encountered in curbing HIV menace. Many infectious 
agents ranging from bacteria, parasites, viruses, contribute 
to immune complex formation in Nigeria. Retention of 
Salmonella-P. falciparum antigens in combination, is a 
leading cause of low CD4 count in HIV positive and negative 
participants. Hence combined infections due to Salmonella 
and malaria may be a major risk factor in HIV infection and 
CD4 count depletion. But not infection due to Salmonella or 
malaria alone. 
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